Patent | Date |
---|
Antigen-binding Molecule Containing Modified Fc Region App 20220242934 - Igawa; Tomoyuki ;   et al. | 2022-08-04 |
Library Of Antigen-binding Molecules Including Modified Antibody Variable Region App 20220040297 - Igawa; Tomoyuki ;   et al. | 2022-02-10 |
Method For Producing Polypeptide Hetero-oligomer App 20220010030 - Igawa; Tomoyuki ;   et al. | 2022-01-13 |
Library of antigen-binding molecules including modified antibody variable region Grant 11,154,615 - Igawa , et al. October 26, 2 | 2021-10-26 |
Anti-cd137 Antigen-binding Molecule And Utilization Thereof App 20210324099 - IGAWA; Tomoyuki ;   et al. | 2021-10-21 |
Method for producing polypeptide hetero-oligomer Grant 11,142,587 - Igawa , et al. October 12, 2 | 2021-10-12 |
Antigen-binding molecule containing modified Fc region Grant 11,142,563 - Igawa , et al. October 12, 2 | 2021-10-12 |
FCgammaRIIB-SPECIFIC FC REGION VARIANT App 20210261648 - Katada; Hitoshi ;   et al. | 2021-08-26 |
Antigen-binding Molecules, The Antigen-binding Activity Of Which Varies According To The Concentration Of Compounds, And Libraries Of Said Molecules App 20210180049 - Igawa; Tomoyuki ;   et al. | 2021-06-17 |
Antigen-binding molecules, the antigen-binding activity of which varies according to the concentration of compounds, and libraries of said molecules Grant 10,961,530 - Igawa , et al. March 30, 2 | 2021-03-30 |
FcgammaRIIB-specific Fc region variant Grant 10,919,953 - Katada , et al. February 16, 2 | 2021-02-16 |
Antigen-binding Molecule Containing Modified Antibody Variable Region App 20200332001 - Igawa; Tomoyuki ;   et al. | 2020-10-22 |
Method For Altering Plasma Retention And Immunogenicity Of Antigen-binding Molecule App 20200199241 - Igawa; Tomoyuki ;   et al. | 2020-06-25 |
Method for altering plasma retention and immunogenicity of antigen-binding molecule Grant 10,618,965 - Igawa , et al. | 2020-04-14 |
Target Tissue-specific Antigen-binding Molecule App 20190359704 - Igawa; Tomoyuki ;   et al. | 2019-11-28 |
Library Of Antigen-binding Molecules Including Modified Antibody Variable Region App 20180296668 - Igawa; Tomoyuki ;   et al. | 2018-10-18 |
Heterodimerized Polypeptide App 20180155451 - Mimoto; Futa ;   et al. | 2018-06-07 |
Method For Producing Polypeptide Hetero-oligomer App 20180057607 - Igawa; Tomoyuki ;   et al. | 2018-03-01 |
Heterodimerized polypeptide Grant 9,890,218 - Mimoto , et al. February 13, 2 | 2018-02-13 |
Antigen-binding Molecules, The Antigen-binding Activity Of Which Varies According To The Concentration Of Compounds, And Libraries Of Said Molecules App 20160304862 - IGAWA; Tomoyuki ;   et al. | 2016-10-20 |
Antigen-binding Molecule Containing Modified Antibody Variable Region App 20160280787 - Igawa; Tomoyuki ;   et al. | 2016-09-29 |
Antigen-Binding Molecule for Promoting Disappearance of Antigen via Fc gamma RIIB App 20160046693 - Igawa; Tomoyuki ;   et al. | 2016-02-18 |
FCgammaRIIB-SPECIFIC FC REGION VARIANT App 20150299296 - Katada; Hitoshi ;   et al. | 2015-10-22 |
Antigen-binding Molecule Containing Modified Fc Region App 20150166636 - Igawa; Tomoyuki ;   et al. | 2015-06-18 |
Target Tissue-specific Antigen-binding Molecule App 20150166654 - Igawa; Tomoyuki ;   et al. | 2015-06-18 |
Heterodimerized Polypeptide App 20140199294 - Mimoto; Futa ;   et al. | 2014-07-17 |
Method For Altering Plasma Retention And Immunogenicity Of Antigen-binding Molecule App 20140105889 - Igawa; Tomoyuki ;   et al. | 2014-04-17 |
Fc-gamma-RIIb-SPECIFIC Fc ANTIBODY App 20140093496 - Mimoto; Futa ;   et al. | 2014-04-03 |
.alpha.-amino acid derivatives and medicaments containing the same as an active ingredient Grant 7,879,887 - Ohrai , et al. February 1, 2 | 2011-02-01 |
Alpha-amino Acid Derivatives And Medicaments Containing The Same As An Active Ingredient App 20090275623 - Ohrai; Kazuhiko ;   et al. | 2009-11-05 |
Peptide derivatives Grant 7,001,887 - Shiraishi , et al. February 21, 2 | 2006-02-21 |
Peptide derivatives App 20040087511 - Shiraishi, Takuya ;   et al. | 2004-05-06 |